U.S. Food and Drug Administration Sr Financial Analyst Salaries in Bloomington, IL
The average U.S. Food and Drug Administration Sr Financial Analyst in Bloomington, IL earns an estimated $90,316 annually, which includes an estimated base salary of $78,565 with a $11,752 bonus. U.S. Food and Drug Administration's Sr Financial Analyst compensation is $2,906 more than the US average for a Sr Financial Analyst. Sr Financial Analyst salaries at U.S. Food and Drug Administration in Bloomington, IL can range from $31,500 - $310,000.
In Bloomington, IL, The Finance Department at U.S. Food and Drug Administration earns $16,015 more on average than the Customer Support Department.
Last updated 3 years ago.
- $78,565
- avg. base
- $11,752
- avg. bonus
Sr Financial Analyst Salaries at U.S. Food and Drug Administration
In Bloomington, IL, Sr Financial Analysts earn $3,365 more than Financial Analysts, and $2,229 less than Senior Accountants.
Compensation at U.S. Food and Drug Administration by Department
In Bloomington, IL, The Finance Department averages $16,015 more than the Customer Support Department, and $19,665 less than the IT Department
Sr Financial Analyst Compensation by Gender (All Companies)
The average female Sr Financial Analyst at companies similar size to U.S. Food and Drug Administration reported making $93,556, while the average male Sr Financial Analyst at similar sized companies reported making $91,853.
Sr Financial Analyst Compensation by Ethnicity (All Companies)
The average Asian or Pacific Islander Sr Financial Analyst at companies similar size to U.S. Food and Drug Administration reported making $98,729, while the average Native American Sr Financial Analyst at similar sized companies reported making $60,000.
How Sr Financial Analysts at U.S. Food and Drug Administration Rate Their Compensation
The majority of Sr Financial Analysts at U.S. Food and Drug Administration believe they're compensated fairly. 100% of Sr Financial Analysts at U.S. Food and Drug Administration say they receive annual bonuses, and the vast majority (71%) are satisfied with their benefits. See more compensation ratings at U.S. Food and Drug Administration
